Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             73 results found
no title author magazine year volume issue page(s) type
1 A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness Goto, Akiko
2003
21 25-26 p. 4043-4051
article
2 Adverse event reporting rates following tetanus–diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991–1997 Lloyd, Jenifer C.
2003
21 25-26 p. 3746-3750
article
3 A highly infective Plasmodium vivax strain adapted to Aotus monkeys: Quantitative haematological and molecular determinations useful for P. vivax malaria vaccine development de Coaña, Yago Pico
2003
21 25-26 p. 3930-3937
article
4 AIDSVAX results: an important open question Veljkovic, Veljko
2003
21 25-26 p. 3528-3529
article
5 Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi Lopez, A.Marianela
2003
21 25-26 p. 3815-3825
article
6 Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus Nakao, Kazuhiko
2003
21 25-26 p. 3789-3794
article
7 A nasal Proteosome™ influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity Jones, Taff
2003
21 25-26 p. 3706-3712
article
8 Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy Iorio, Anna M.
2003
21 25-26 p. 3629-3637
article
9 Antigen dependent adverse reactions and seroconversion of a tick-borne encephalitis vaccine in children Eder, G
2003
21 25-26 p. 3575-3583
article
10 Anti-PsaA and the risk of pneumococcal AOM and carriage Rapola, Satu
2003
21 25-26 p. 3608-3613
article
11 A pilot study to quantify parental anxiety associated with enrollment of an infant or toddler in a phase III vaccine trial Langley, Joanne M
2003
21 25-26 p. 3863-3866
article
12 Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination—an impact of immunosenescence Trzonkowski, Piotr
2003
21 25-26 p. 3826-3836
article
13 A synthetic peptide containing the consensus sequence of the G–H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge Rodriguez, Luis L.
2003
21 25-26 p. 3751-3756
article
14 Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada De Wals, Philippe
2003
21 25-26 p. 3757-3764
article
15 Boosting of SIV-specific immune responses in rhesus macaques by repeated administration of Ad5hr–SIVenv/rev and Ad5hr–SIVgag recombinants Zhao, Jun
2003
21 25-26 p. 4022-4035
article
16 Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody Lodmell, Donald L.
2003
21 25-26 p. 3998-4002
article
17 Comparative analysis of effects of cytokine gene adjuvants on DNA vaccination against Mycobacterium tuberculosis heat shock protein 65 Baek, Kyoung Min
2003
21 25-26 p. 3684-3689
article
18 Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus Riemenschneider, Jenny
2003
21 25-26 p. 4071-4080
article
19 Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice Konishi, Eiji
2003
21 25-26 p. 3675-3683
article
20 Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe Trimble, Cornelia
2003
21 25-26 p. 4036-4042
article
21 Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa–HBV–IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered as a single injection, with the DTPa–IPV/Hib and hepatitis B vaccines administered in two simultaneous injections to infants at 2, 4 and 6 months of age Arı́stegui, J
2003
21 25-26 p. 3593-3600
article
22 Cost–benefit analysis of routine childhood vaccination against chickenpox in Taiwan: decision from different perspectives Hsu, Hui-Chun
2003
21 25-26 p. 3982-3987
article
23 Cost-effectiveness of hepatitis A vaccine in prevention of secondary hepatitis A infection Péchevis, Marc
2003
21 25-26 p. 3556-3564
article
24 Cross-protection between distantly related spotted fever group rickettsiae Feng, Hui-min
2003
21 25-26 p. 3901-3905
article
25 Cytokine production patterns and antibody response to measles vaccine Ovsyannikova, Inna G.
2003
21 25-26 p. 3946-3953
article
26 Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion Myc, Andrzej
2003
21 25-26 p. 3801-3814
article
27 Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation Sheikh, Nadeem A.
2003
21 25-26 p. 3775-3788
article
28 Editorial Board/Aims and Scope 2003
21 25-26 p. IFC
article
29 Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up Hedlund, J.
2003
21 25-26 p. 3906-3911
article
30 Enhancement of immunity against VZV by giving live varicella vaccine to the elderly assessed by VZV skin test and IAHA, gpELISA antibody assay Takahashi, Michiaki
2003
21 25-26 p. 3845-3853
article
31 Erratum to “Influenza vaccine uptake in the elderly: results from a rapid assessment of new government policy in England for the winters 2000/2001 and 2001/2002” [Vaccine 21 (2003) 1137–1148] Joseph, Carol
2003
21 25-26 p. 4094
article
32 Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice Wu, Shu-Fen
2003
21 25-26 p. 3919-3929
article
33 Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates Jin, Hong
2003
21 25-26 p. 3647-3652
article
34 Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits Eko, Francis O.
2003
21 25-26 p. 3663-3674
article
35 Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease Gipson, Clay L.
2003
21 25-26 p. 3875-3884
article
36 Evidence for antigen production in muscles by dengue and Japanese encephalitis DNA vaccines and a relation to their immunogenicity in mice Konishi, Eiji
2003
21 25-26 p. 3713-3720
article
37 Expression of a recombinant gag protein from endogenous avian virus and its use in screening for antibody reactivity in recipients of chick-derived vaccines Johnson, Jeffrey A
2003
21 25-26 p. 3738-3745
article
38 False positive HBsAg result in blood donors due to administration of three different recombinant DNA Hepatitis B vaccines Otağ, Feza
2003
21 25-26 p. 3734-3737
article
39 Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100 Marciani, Dante J
2003
21 25-26 p. 3961-3971
article
40 Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models Pratt, William D
2003
21 25-26 p. 3854-3862
article
41 Genetic and phenotypic analysis of reassortants of high growth and low growth strains of influenza B virus Vodeiko, G.M
2003
21 25-26 p. 3867-3874
article
42 Human T-cells recognise N-terminally Fmoc-modified peptide Mannering, Stuart I.
2003
21 25-26 p. 3638-3646
article
43 Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice Bertolotti-Ciarlet, Andrea
2003
21 25-26 p. 3885-3900
article
44 Immunogenicity of combined hepatitis A and B vaccine in elderly persons Wolters, Bernd
2003
21 25-26 p. 3623-3628
article
45 Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies Lagos, Rosanna
2003
21 25-26 p. 3730-3733
article
46 Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D Domingo, C.
2003
21 25-26 p. 3565-3574
article
47 Induction of antigen-specific systemic and mucosal immune responses by feeding animals transgenic plants expressing the antigen Bae, Jong-Lye
2003
21 25-26 p. 4052-4058
article
48 Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine Wu, Chang-Jer
2003
21 25-26 p. 3938-3945
article
49 Induction of immunity in swine by purified recombinant VP1 of foot-and-mouth disease virus Wang, Jeng-Hwan
2003
21 25-26 p. 3721-3729
article
50 Influenza and other vaccine uptake in the elderly in England Arya, S.C
2003
21 25-26 p. 3527
article
51 Influenza coverages in Spain and vaccination-related factors in the subgroup aged 50–64 years Jiménez, Rodrigo
2003
21 25-26 p. 3550-3555
article
52 Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs van den Bosch, Han
2003
21 25-26 p. 3601-3607
article
53 Interferon-gamma-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis Pinto, Eduardo Fonseca
2003
21 25-26 p. 3534-3541
article
54 Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis Storsaeter, Jann
2003
21 25-26 p. 3542-3549
article
55 Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA Marinaro, Mariarosaria
2003
21 25-26 p. 3972-3981
article
56 Mycobacterium tuberculosis arabinomannan–protein conjugates protect against tuberculosis Hamasur, Beston
2003
21 25-26 p. 4081-4093
article
57 Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates Marchart, J.
2003
21 25-26 p. 3988-3997
article
58 Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs Nguyen, T.V
2003
21 25-26 p. 4059-4070
article
59 Protective efficacy of a fully recombinant plague vaccine in the guinea pig Jones, S.M
2003
21 25-26 p. 3912-3918
article
60 Rabies in a Thai child treated with the eight-site post-exposure regimen without rabies immune globulin Sriaroon, Chakrapol
2003
21 25-26 p. 3525-3526
article
61 Response to hepatitis-B vaccination in healthy homosexual individuals: retrospective case control study Das, Satyajit
2003
21 25-26 p. 3701-3705
article
62 Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer Zent, O
2003
21 25-26 p. 3584-3592
article
63 Seroprevalence of rubella antibodies in the State of São Paulo, Brazil, 8 years after the introduction of vaccine Zanetta, Dirce M.T.
2003
21 25-26 p. 3795-3800
article
64 Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies Smith, Mark L.
2003
21 25-26 p. 4011-4021
article
65 The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines Baudner, Barbara C
2003
21 25-26 p. 3837-3844
article
66 The outer membrane protein X from Escherichia coli exhibits immune properties Maisnier-Patin, Karine
2003
21 25-26 p. 3765-3774
article
67 The pertussis vaccine controversy in Great Britain, 1974–1986 Baker, Jeffrey P.
2003
21 25-26 p. 4003-4010
article
68 The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine Schmitt, H.J
2003
21 25-26 p. 3653-3662
article
69 Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing 2003
21 25-26 p. 3503-3524
article
70 Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background Chen, Wangxue
2003
21 25-26 p. 3690-3700
article
71 Unintended events following immunization with MMR: a systematic review Jefferson, Tom
2003
21 25-26 p. 3954-3960
article
72 Vaccination programmes in the Italian military D’Amelio, Raffaele
2003
21 25-26 p. 3530-3533
article
73 Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination Hanslik, Thomas
2003
21 25-26 p. 3614-3622
article
                             73 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands